prikaz prve stranice dokumenta Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis
  Download
PDF 137.03 KB
Scientific paper - Original scientific paper
Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis
Croatian Medical Journal, 58 (2017), 5; 342-348. urn:nbn:hr:105:764877
Drulović, Jelena; Gavrilović, Anđela; Crnošija, Luka; Kisić-Tepavčević, Darija; Krbot Skorić, Magdalena; Ivanović, Jovana; Adamec, Ivan; Dujmović, Irena; Junaković, Anamari; Marić, Gorica; Martinović, Vanja; Pekmezović, Tatjana; Habek, Mario

Cite this document

Drulović, J., Gavrilović, A., Crnošija, L., Kisić Tepavčević, D., Krbot Skorić, M., Ivanović, J. ... Habek, M. (2017). Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis. Croatian Medical Journal, 58. (5), 342-348. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:764877

Drulović, Jelena, et al. "Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis." Croatian Medical Journal, vol. 58, no. 5, 2017, pp. 342-348. https://urn.nsk.hr/urn:nbn:hr:105:764877

Drulović, Jelena, Anđela Gavrilović, Luka Crnošija, Darija Kisić Tepavčević, Magdalena Krbot Skorić, Jovana Ivanović, Ivan Adamec, et al. "Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis." Croatian Medical Journal 58, no. 5 (2017): 342-348. https://urn.nsk.hr/urn:nbn:hr:105:764877

Drulović, J., et al. (2017) 'Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis', Croatian Medical Journal, 58(5), pp. 342-348. Available at: https://urn.nsk.hr/urn:nbn:hr:105:764877 (Accessed 11 November 2024)

Drulović J, Gavrilović A, Crnošija L, Kisić Tepavčević D, Krbot Skorić M, Ivanović J, and sur.. Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis. Croatian Medical Journal [Internet]. 2017 October 31 [cited 2024 November 11];58(5):342-348. Available at: https://urn.nsk.hr/urn:nbn:hr:105:764877

J. Drulović, et al., "Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis", Croatian Medical Journal, vol. 58, no. 5, pp. 342-348, October 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:764877. [Accessed: 11 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis
AuthorJelena Drulović
AuthorAnđela Gavrilović
AuthorLuka Crnošija
AuthorDarija Kisić-Tepavčević
AuthorMagdalena Krbot Skorić
AuthorJovana Ivanović
AuthorIvan Adamec
AuthorIrena Dujmović
AuthorAnamari Junaković
AuthorGorica Marić
AuthorVanja Martinović
AuthorTatjana Pekmezović
AuthorMario Habek
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
AIM: To validate and cross-culturally adapt Croatian and Serbian versions of composite autonomic symptom score-31 (COMPASS-31) for the detection of dysautonomia in patients with multiple sclerosis (MS). ----- METHODS: A total of 179 patients, 67 with clinically isolated syndrome (CIS) and 112 with MS, completed the COMPASS-31 at two MS centers in Zagreb and Belgrade between April 1 and October 31, 2016. Demographic and clinical data including age, gender, MS phenotypes, and the Expanded Disability Status Scale (EDSS) score were collected. ----- RESULTS: The Cronbach's alpha coefficient of COMPASS-31 total score was 0.844 for the Croatian MS sample and 0.779 for the Serbian MS sample. A joint analysis yielded Cronbach's alpha coefficients ranging from 0.394 to 0.796, with values in four domains higher than 0.700. In Croatian and Serbian samples and the total study sample, the Cronbach's alpha coefficient of COMPASS-31 was 0.785. Reproducibility measured by intra-class correlation coefficient (ICC) was acceptable (ICC=0.795). With regard to the clinical validity, significant correlation was found between EDSS and the COMPASS-31 total score (P<0.001). Furthermore, significant differences between MS phenotypes were detected for bladder and gastrointestinal domains and for the COMPASS-31 total score (PP<0.001, P=0.005, and P=0.027, respectively). Finally, significant differences between MS phenotypes in patients with score >0, which implies the existence of at least one of the symptoms investigated in each domain, were detected for secretomotor and bladder domains (P=0.015 and PP<0.001, respectively). ----- CONCLUSION: COMPASS-31 represents a valid and acceptable self-assessment instrument for the detection of dysautonomia in MS patients.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleCroatian Medical Journal
Numberingvol. 58, no. 5, pp. 342-348
p-ISSN0353-9504
URN:NBNurn:nbn:hr:105:764877
Publication2017-10-31
Document URLhttp://www.cmj.hr/2017/58/5/29094812.htm
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 09:14:58